IMPACT BIOMEDICAL INC. Business Finance Contracts & Agreements
34 Contracts & Agreements
- Exchange Agreements (5 contracts)
- Note Agreements (14)
- Stock Agreements (2)
- Subscription Agreements (2)
- Underwriting Agreements (6)
- Warrant Agreements (5)
- Underwriting Agreement dated September 16, 2024 between the Company and Revere Securities LLC (Filed With SEC on September 17, 2024)
- Amendment to Promissory Note effective January 18, 2024 between Impact BioMedical Inc. and DSS, Inc (Filed With SEC on August 20, 2024)
- Form of Underwriter Warrant (Filed With SEC on August 20, 2024)
- Form of Underwriting Agreement between the Company and Revere Securities, LLC and Dawson James Securities Inc (Filed With SEC on August 20, 2024)
- Amendment to Promissory Note effective January 18, 2024 between Impact BioMedical Inc. and DSS, Inc (Filed With SEC on June 11, 2024)
- Form of Underwriter Warrant (Filed With SEC on June 11, 2024)
- Form of Underwriting Agreement between the Company and Revere Securities, LLC (Filed With SEC on June 11, 2024)
- Amendment to Promissory Note effective January 18, 2024 between Impact BioMedical Inc. and DSS, Inc (Filed With SEC on February 28, 2024)
- Form of Underwriter Warrant (Filed With SEC on February 28, 2024)
- Form of Underwriting Agreement between the Company and Aegis Capital Corp (Filed With SEC on February 28, 2024)
- Amendment to Promissory Note effective January 18, 2024 between Impact BioMedical Inc. and DSS, Inc (Filed With SEC on January 22, 2024)
- Share Exchange Agreement between Impact BioMedical Inc. and DSS BioHealth Security, Inc (Filed With SEC on November 21, 2023)
- Form of Underwriter Warrant (Filed With SEC on November 21, 2023)
- Form of Underwriting Agreement between the Company and Aegis Capital Corp (Filed With SEC on November 21, 2023)
- Share Exchange Agreement between Impact BioMedical Inc. and DSS BioHealth Security, Inc., dated October 31, 2023 (Filed With SEC on November 6, 2023)
- Share Exchange Agreement between Impact BioMedical Inc. and DSS BioHealth Security, Inc (Filed With SEC on November 1, 2023)
- Form of Underwriter Warrant (Filed With SEC on November 1, 2023)
- Form of Underwriting Agreement between the Company and Aegis Capital Corp (Filed With SEC on November 1, 2023)
- Subscription Agreement dated December 19, 2020, between the Company and BioMed Technologies Asia Pacific Holdings Limited (Filed With SEC on October 17, 2023)
- Share Exchange Agreement dated as of April 27, 2020, among Document Security Systems, Inc., DSS BioHealth Security, Inc., Singapore eDevelopment Limited and Global BioMedical Pte... (Filed With SEC on October 17, 2023)
- Promissory Note with Dustin Michael Crum dated February 21, 2021 (Filed With SEC on August 24, 2022)
- Amendment No. 2 to Revolving Promissory Note dated March 31, 2022 (Filed With SEC on August 2, 2022)
- Amendment No. 1 to Revolving Promissory Note dated December 31, 2021 (Filed With SEC on August 2, 2022)
- Revolving Promissory Note dated December 31, 2020 (Filed With SEC on August 2, 2022)
- Subscription Agreement dated December 19, 2020, between the Company and BioMed Technologies Asia Pacific Holdings Limited (Filed With SEC on August 2, 2022)
- Convertible Promissory Note dated May 14, 2021 (Filed With SEC on June 24, 2022)
- Stock Purchase Agreement dated March 15, 2021 between the Company and Vivacitas Oncology Inc (Filed With SEC on June 24, 2022)
- Share Exchange Agreement dated as of April 27, 2020, among Document Security Systems, Inc., DSS BioHealth Security, Inc., Singapore eDevelopment Limited and Global BioMedical Pte... (Filed With SEC on September 29, 2021)
- Amendment No. 2 to Revolving Promissory Note dated March 31, 2022 (Filed With SEC on October 17, 2023)
- Amendment No. 1 to Revolving Promissory Note dated December 31, 2021 (Filed With SEC on October 17, 2023)
- Revolving Promissory Note dated December 31, 2020 (Filed With SEC on October 17, 2023)
- Convertible Promissory Note dated May 14, 2021 (Filed With SEC on October 17, 2023)
- Stock Purchase Agreement dated March 15, 2021 between the Company and Vivacitas Oncology Inc (Filed With SEC on October 17, 2023)
- Promissory Note with Dustin Michael Crum dated February 21, 2021 (Filed With SEC on October 17, 2023)
